How RNA-Encoded Cytokines Mediate Potent Anti-Tumor Activity When Combined With Immune Checkpoint Blockade Or Cancer Vaccines

Time: 11:00 am
day: Pre-Event Content


  • Uncover how delivery of cytokines by RNA lipid nanoparticles can overcome the disadvantages of classical therapies like short half-life or low tolerability
  • Learn how the therapeutic potential of IL-2 can be improved by optimizing it’s binding profile or by combination with IL-7
  • See how RNA-encoded cytokines significantly boost the efficacy of immune checkpoint blockade or cancer vaccines